anti-GPC3 CAR-T cell therapy (CRISPR Therapeutics/Roswell Park Cancer Institute)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2025/03/14 16:28:53

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐanti-GPC3 CAR-T cell therapy (CRISPR Therapeutics/Roswell Park Cancer Institute)
่ฏ็‰ฉๅˆซ็งฐN/A
่ฏ็‰ฉ็ฑปๅž‹็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ๅ…็–ซ็ป†่ƒž็–—ๆณ• > ๆท‹ๅทด็ป†่ƒž็–—ๆณ• > T็ป†่ƒž็–—ๆณ• > ๅตŒๅˆๆŠ—ๅŽŸๅ—ไฝ“T็ป†่ƒž็–—ๆณ•๏ผˆCAR-T๏ผ‰็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ๅŸบๅ› ็–—ๆณ• > ๅŸบๅ› ็ผ–่พ‘ > CRISPR > CRISPR-Cas9็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ้‡็ป„่›‹็™ฝ > ่žๅˆ่›‹็™ฝ
ไฝœ็”จๆœบๅˆถ็ฃท่„‚้…ฐ่‚Œ้†‡่š็ณ–3่ฐƒ่Š‚ๅ‰‚
้ถ็‚น็ฃท่„‚้…ฐ่‚Œ้†‡่š็ณ–3
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡่‚็ป†่ƒž็™Œ
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ็‘žๅฃซ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ไธดๅบŠๅ‰
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธCrispr Therapeutics Ag
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธRoswell Park Comprehensive Cancer CenterCrispr Therapeutics Ag
้žๆดป่ทƒๅ…ฌๅธN/A
ๆดป่ทƒ้€‚ๅบ”็—‡่‚็ป†่ƒž็™Œ
้žๆดป่ทƒ้€‚ๅบ”็—‡N/A

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A